For decades, medicine has measured the invisible through the mundane — how often a woman changes a tampon — trusting that this small act could reveal something serious about her health. But as menstruating people quietly shifted toward cups, discs, and period underwear, the diagnostic language stayed behind. A study from Oregon Health & Science University now makes plain what was hiding in that gap: a product holding 80 times more blood than another renders the old questions meaningless, and with them, the diagnoses that depend on honest answers.
News-Medical.net
· Aug 10, 2023
· health
· 4 min de leitura
High
Apuração: Verificado
Study reveals modern menstrual products mask heavy bleeding diagnosis
Heavy menstrual bleeding affects approximately one-third of menstruating people and can lead to iron deficiency and other serious health conditions if undiagnosed.
◉
Health & Medicine
8464 artigos relacionados
Retatrutide: Eli Lilly's Triple-Action Weight-Loss Drug Poised to Resh…
The Economic Times · 100% correspondência
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight-Loss Treatment
Interesting Engineering · 99% correspondência
Eli Lilly's Oral GLP-1 Pill Shows Promise for Diabetes and Weight Loss
TODAY · 99% correspondência
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight Loss Drug
ScienceAlert · 99% correspondência
Moderna's personalized mRNA melanoma vaccine shows promise in preventi…
CBS News · 99% correspondência
Cobertura Relacionada
The Guardian · Aug 26
ADHD and autism complaints triple as NHS waits stretch to years
Complaints about autism and ADHD services in England tripled in five years as NHS waits exceed a year for most patients,…
News-Medical · Aug 26 Sewage monitoring detects pertussis outbreaks 10 weeks earlier than clinical reportsWastewater surveillance in Osaka detected pertussis DNA 4-16 weeks before clinical case reports, offering a proactive ea…
The Hindu · Aug 26 India's H1N1 surge is seasonal, not a new strain, ICMR assuresIndia experiences seasonal H1N1 rise with 1,777 cases in Delhi and 4,212 in Karnataka; ICMR confirms it's the familiar p…
Medical Xpress · Aug 26 Stress gene hyperactivity linked to schizophrenia in University of Sydney studyUniversity of Sydney researchers discovered that a stress-regulating gene (FKBP5) remains abnormally active in schizophr…
Viés e Enquadramento
⚖
Medical news article presenting research findings on menstrual product absorption capacity with minimal apparent bias, though framing emphasizes diagnostic challenges.
Bias Direction
center
Confidence
MED
Problem-solution framing that highlights a clinical gap: newer menstrual products lack standardized testing and diagnostic criteria, creating challenges for HMB diagnosis. The article frames this as a healthcare system issue requiring attention rather than advocating for particular products or policies.
mask heavy bleeding diagnosis
vastly different absorption capacities
adds frustration to the patient experience
surge in availability
Menstrual product manufacturers' responses or counter-arguments
Patient experiences or preferences regarding newer products
Cost-benefit analysis of updating diagnostic tools
Timeline or feasibility for implementing new diagnostic standards
Perspectives from gynecologists on practical implementation challenges
Impacto Geopolítico
🌎
Medical research article on menstrual product absorption capacity has no geopolitical implications; assessment not applicable to international relations.
Escalation Risk
N/A
Confidence
HIGH
Lente Econômica
📈
Medical diagnostic gaps in menstrual product assessment may lead to underdiagnosis of heavy bleeding, affecting healthcare quality and creating market opportunities for standardized testing and diagnostic tools.
Market Signal
mixed
Confidence
MED
Healthcare/Medical Devices
Menstrual Product Manufacturing
Diagnostic Testing/Laboratory Services
Pharmaceutical (iron supplements, HMB treatments)
Medical Technology/Software
Consumers using newer menstrual products (cups, discs, period underwear) may experience delayed or missed diagnoses of heavy menstrual bleeding, leading to untreated iron deficiency, reduced quality of life, and increased out-of-pocket healthcare costs. Conversely, standardization could improve health outcomes and product choice confidence.
Regulatory bodies (FDA, international standards organizations) may need to: (1) mandate standardized absorption testing for all menstrual products using actual menstrual fluid equivalents, not just water; (2) update clinical diagnostic criteria (PBAC) to account for modern product variations; (3) require manufacturers to disclose absorption capacity comparably; (4) potentially increase healthcare provider training on HMB assessment with diverse product use.